US Broker Ratings

Alnylam Pharmaceuticals (ALNY) Stock Analysis: Impressive Revenue Growth and 22.93% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering force in the biotechnology sector, is capturing significant investor attention due to its remarkable revenue growth and substantial potential upside. With a market..

Tempus AI, Inc. (TEM) Stock Analysis: Unpacking the 42.59% Potential Upside Amidst Healthcare Tech Revolution

Tempus AI, Inc. (TEM), a prominent player in the healthcare technology sector, is garnering significant attention from investors, thanks to its innovative approach to health information services and a striking..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 27.81% Potential Upside with Strong Buy Ratings

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has emerged as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in San Diego, California, this..

Boston Scientific Corporation (BSX) Stock Analysis: A 32.89% Potential Upside Beckons Investors

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a notable potential upside of 32.89%. This Massachusetts-based company..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating the Biotech Giant’s Growth Potential and Analyst Ratings

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, with a market capitalization of $82.28 billion and a diverse portfolio of products addressing some of..

Exelixis, Inc. (EXEL): Investor Outlook on a Biotech Powerhouse with a 30.56% Return on Equity

Exelixis, Inc. (NASDAQ: EXEL) is a prominent player in the biotechnology sector, with a specific focus on oncology, developing and commercializing medicines for challenging cancer types. Situated in the healthcare..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating 12.27% Potential Upside with Strong Buy Ratings

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry, stands as a prominent investment option within the healthcare sector. With a market capitalization of $50.1 billion,..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 19% Upside Potential Amidst Revenue Challenges

As individual investors assess the landscape of biotechnology stocks, Moderna, Inc. (NASDAQ: MRNA) presents an intriguing case. With its current market cap standing at $12.06 billion, Moderna operates in the..

Pfizer, Inc. (PFE) Stock Analysis: Potential 13.67% Upside with a Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, is known for its innovative approach in the drug manufacturing industry. With a market capitalization of $143.17 billion, Pfizer stands..

Stryker Corporation (SYK) Stock Analysis: Unpacking the 22.96% Potential Upside

Stryker Corporation (NYSE: SYK), a stalwart in the healthcare sector, is catching the eyes of investors with its robust market presence and promising growth prospects. With a substantial market capitalization..

DaVita Inc. (DVA) Stock Analysis: Exploring a 26% Potential Upside for Investors

DaVita Inc. (NYSE: DVA) is making waves in the healthcare sector, with a market capitalization of $8.19 billion. Specializing in kidney dialysis services, this Denver-based company offers critical medical care..

Dr. Reddy’s Laboratories Ltd (RDY): Growth Potential and Analyst Consensus Highlight Investment Opportunities

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector and a key figure in the drug manufacturing industry, is drawing attention from investors worldwide. With a..

Genmab A/S (GMAB) Stock Analysis: Strong Upside Potential with 18.84% on the Horizon

Genmab A/S (GMAB), a Danish biotechnology powerhouse, stands out in the healthcare sector with a robust market capitalization of $19.73 billion. Known for its innovative antibody-based therapies targeting cancer and..

Waters Corporation (WAT) Stock Analysis: Solid Performance in Diagnostics & Research with 6.38% Upside Potential

Waters Corporation (NYSE: WAT), a key player in the Healthcare sector, particularly within the Diagnostics & Research industry, is making waves with its robust financial metrics and promising outlook. Headquartered..

Tenet Healthcare Corporation (THC) Stock Analysis: A Promising 18.95% Upside for Investors

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable entity in the medical care facilities industry, boasting a diverse portfolio of services and a strong market presence in the United..

Baxter International Inc. (BAX) Stock Analysis: Exploring the 21.37% Potential Upside Amid Turbulent Financials

Baxter International Inc. (NYSE: BAX) represents a compelling case study for investors navigating the healthcare sector. With a market capitalization of $10.02 billion, Baxter operates in the medical instruments and..

Humana Inc. (HUM) Stock Analysis: Healthcare Giant’s Growth Potential and Analyst Ratings

As a major player in the healthcare sector, Humana Inc. (HUM) stands out for its robust service offerings and strategic contracts in the United States. With a market capitalization of..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

The Cooper Companies, Inc. (COO) Stock Analysis: Insights into a Potential 11.58% Upside

The Cooper Companies, Inc. (NYSE: COO) is a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $16.13 billion, Cooper..

The Cigna Group (CI) Investor Outlook: Robust Revenue Growth and 16% Potential Upside

For investors eyeing the healthcare sector, The Cigna Group (NYSE: CI) presents a compelling opportunity. With a market capitalization of $74.56 billion, Cigna is a heavyweight in the healthcare plans..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds